Pure MHC
About Pure MHC
Pure MHC is a platform technology company funded and managed by Emergent Technologies, Inc. with expertise in disease-specific target identification and validation as well as immunotherapeutic drug development for cancer, infectious and autoimmune diseases, and allergy.
Pure MHC Headquarter Location
7500 Rialto Blvd Bldg. 2, Ste. 260
Austin, Texas, 78735,
United States
512-697-8167
Expert Collections containing Pure MHC
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pure MHC is included in 1 Expert Collection, including Cancer.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Latest Pure MHC News
Apr 8, 2022
OKLAHOMA CITY, Okla. /Massachusetts Newswire - National News/ -- Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC's proprietary offering of MHC peptide targets for oncology with Myrio's revolutionary Retained Display(tm) (ReD) antibody discovery process to initially create up to three novel therapies based on targets distinct to tumors across multiple types of cancer. The post Myrio Therapeutics and Pure MHC Announce Collaboration to Research and Develop Novel, Targeted Antibody-Based Cancer Therapies appeared first on Massachusetts Newswire.
Where is Pure MHC's headquarters?
Pure MHC's headquarters is located at 7500 Rialto Blvd, Austin.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.